Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

AptarGroup, Inc. Common Stock (NY:ATR)

153.32 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, May 9, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about AptarGroup, Inc. Common Stock

< Previous 1 2 3 4 5 6 Next >
Aptar Announces New $500 Million Share Repurchase Authorization and Declares Quarterly Dividend
From AptarGroup, Inc.
Via Business Wire
Aptar’s N-Sorb Nitrosamine Mitigation Solution Accepted to US FDA’s Emerging Technology Program
From AptarGroup, Inc.
Via Business Wire
How Is The Market Feeling About AptarGroup?
Via Benzinga
Green Day Has The Right Idea As September Seasonality Comes In Hot
In this video, I analyze our current market condition and leading ETFs as we move through September's historically weak seasonality. 
Via Talk Markets
Topics ETFs
Looking Into AptarGroup's Recent Short Interest
Via Benzinga
How Is The Market Feeling About AptarGroup?
Via Benzinga
Earnings Scheduled For February 8, 2024
Companies Reporting Before The Bell • Ares Management (NYSE:ARES) is expected to report quarterly earnings at $1.09 per share on revenue of $864.54 million. 
Via Benzinga
Tuesday Is Your Last Chance To Buy AptarGroup Before The Dividend Payout
Via Benzinga
Aptar’s Nasal Unidose System to Deliver neffy® (epinephrine nasal spray), the First and Only FDA-Approved Needle-Free Treatment for Type I Allergic Reactions, Including Anaphylaxis
From AptarGroup, Inc.
Via Business Wire
ATR Stock Earnings: AptarGroup Beats EPS, Misses Revenue for Q2 2024
ATR stock results show that AptarGroup beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. 
Via InvestorPlace
Daniel Ackerman Named Aptar’s Chief Accounting Officer
From AptarGroup, Inc.
Via Business Wire
Aptar CFO, Robert (Bob) Kuhn, Has Decided to Step Down After 37 Years with the Company
From AptarGroup, Inc.
Via Business Wire
Aptar Reports Second Quarter 2024 Results
From AptarGroup, Inc.
Via Business Wire
Aptar Increases Quarterly Dividend by Nearly 10% Due to Continued Strong Performance
From AptarGroup, Inc.
Via Business Wire
Aptar Named One of the World’s Most Sustainable Companies 2024 by TIME
From AptarGroup, Inc.
Via Business Wire
Aptar Named One of America’s Climate Leaders by USA Today
From AptarGroup, Inc.
Via Business Wire
Aptar Releases 2023 Corporate Sustainability / ESG Report
From AptarGroup, Inc.
Via Business Wire
Aptar Receives Platinum Rating from EcoVadis for the Fourth Consecutive Year
From AptarGroup, Inc.
Via Business Wire
ATR Stock Earnings: AptarGroup Beats EPS, Beats Revenue for Q1 2024
ATR stock results show that AptarGroup beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
Aptar Reports First Quarter 2024 Results
From AptarGroup, Inc.
Via Business Wire
Aptar Declares Quarterly Dividend
From AptarGroup, Inc.
Via Business Wire
Aptar Named a CDP Supplier Engagement Leader for the Fourth Consecutive Year
From AptarGroup, Inc.
Via Business Wire
Aptar Named One of Barron’s 100 Most Sustainable U.S. Companies for the Sixth Consecutive Year
From AptarGroup, Inc.
Via Business Wire
Aptar Signs Enterprise Agreement with Biogen to Operate and Develop Digital Health Solutions
From AptarGroup, Inc.
Via Business Wire
Aptar Reports Fourth Quarter and Annual 2023 Results
From AptarGroup, Inc.
Via Business Wire
Aptar Named One of America’s Most Responsible Companies by Newsweek for the Fifth Consecutive Year
From AptarGroup, Inc.
Via Business Wire
Aptar Declares Quarterly Dividend and Announces 2024 Annual Meeting Details
From AptarGroup, Inc.
Via Business Wire
Aptar to Present at 42nd Annual J.P. Morgan Healthcare Conference on January 11, 2024
From AptarGroup, Inc.
Via Business Wire
Aptar Announces 2024 Quarterly Conference Call Dates
From AptarGroup, Inc.
Via Business Wire
Aptar Awarded US FDA Contract to Study Opportunities for Low Global Warming Potential Propellants for Metered Dose Inhalers
From AptarGroup, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.